Mesotherapy with dutasteride in the treatment of androgenetic alopecia



David Saceda-Corralo, Ana Rita Rodrigues-Barata, Sergio Vano-Galvan, Pedro Jaen-Olasolo

Department of Dermatology, Ramón Y Cajal Hospital; Trichology Unit, Dermatology Clinic Grupo Pedro Jaén, Madrid, Spain



Correspondence Address:

David Saceda-Corralo

Hospital, Carretera Colmenar Viejo, Km. 9.100, 28034 Madrid

Spain

Source of Support: None, Conflict of Interest: None Check

DOI: 10.4103/ijt.ijt_73_16





1. et al. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebo-controlled, phase III study. J Am Acad Dermatol 2010;63:252-8.

[PUBMED] Eun HC, Kwon OS, Yeon JH, Shin HS, Kim BY, Ro BI,Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebo-controlled, phase III study. J Am Acad Dermatol 2010;63:252-8.

2.

Abdallah MA, El-Zawahry KA, Besar H. Mesotherapy using dutasteride-containing solution in male pattern hair loss: A controlled pilot study. J Pan Arab Leag Dermatol 2009;20:137-45.

3. et al. Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: Photographic, morphometric and ultrustructural evaluation. J Eur Acad Dermatol Venereol 2013;27:686-93.

Moftah N, Moftah N, Abd-Elaziz G, Ahmed N, Hamed Y, Ghannam B,Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: Photographic, morphometric and ultrustructural evaluation. J Eur Acad Dermatol Venereol 2013;27:686-93.

4.

Sobhy N, Aly H, El Shafee A, El Deeb M. Evaluation of the effect of injection of dutasteride as mesotherapeutic tool in treatment of androgenetic alopecia in males. Our Dermatol Online 2013;4:40-5.